Conmed (CNMD) EBT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.53% |
| Dec 31, 2025 | 16.73% |
| Sep 30, 2025 | -24.44% |
| Jun 30, 2025 | 23.85% |
| Mar 31, 2025 | 17.06% |
| Dec 31, 2024 | 20.41% |
| Sep 30, 2024 | 42.99% |
| Jun 30, 2024 | 42.00% |
| Mar 31, 2024 | 71.85% |
| Dec 31, 2023 | 14.92% |
| Sep 30, 2023 | 26.31% |
| Jun 30, 2023 | 8.49% |
| Mar 31, 2023 | -27.80% |
| Dec 31, 2022 | -20.83% |
| Sep 30, 2022 | 12.64% |
| Jun 30, 2022 | -67.41% |
| Mar 31, 2022 | 35.92% |
| Dec 31, 2021 | 27.80% |
| Sep 30, 2021 | 11.80% |
| Jun 30, 2021 | 32.91% |
| Mar 31, 2021 | 38.03% |
| Dec 31, 2020 | 3.46% |
| Sep 30, 2020 | 5.41% |
| Jun 30, 2020 | -37.95% |
| Mar 31, 2020 | -18.13% |
| Dec 31, 2019 | 2.08% |
| Sep 30, 2019 | 59.70% |
| Jun 30, 2019 | -14.68% |
| Mar 31, 2019 | -16.25% |
| Dec 31, 2018 | 6.66% |
| Sep 30, 2018 | -3.20% |
| Jun 30, 2018 | -4.07% |
| Mar 31, 2018 | -2.64% |
| Dec 31, 2017 | 3.21% |
| Sep 30, 2017 | -7.46% |
| Jun 30, 2017 | -11.57% |
| Mar 31, 2017 | -19.38% |
| Dec 31, 2016 | 17.07% |
| Sep 30, 2016 | -5.34% |
| Jun 30, 2016 | -22.31% |
| Mar 31, 2016 | -17.35% |
| Dec 31, 2015 | 1.39% |
| Sep 30, 2015 | 1.47% |
| Jun 30, 2015 | -1.65% |